In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Case Number:
2:17-md-02785
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Barnow & Associates
- Baron & Budd
- Barton & Burrows
- Beasley Allen
- Berkowitz Oliver
- Berman Tabacco
- Blood Hurst
- Boies Schiller
- Bradford & Wilson
- Burns Charest
- Bush Seyferth
- Butler Prather
- Carella Byrne
- Clark Hill
- DiCello Levitt
- Dollar Burns
- Foley & Lardner
- Foulston Siefkin
- Fredrikson & Byron
- Freshfields
- Gibbons PC
- Gibbs Law Group
- Gibson Dunn
- GM Law PC
- Goldman Scarlato
- Goodwin Procter
- Groom Law Group
- Gustafson Gluek
- Hagens Berman
- Hinkle Law Firm
- Hogan Lovells
- Holland & Knight
- Horn Aylward
- Joseph Saveri Law Firm
- Kaufman & Canoles
- Keller Rohrback
- King & Spalding
- Kramer Levin
- Lanier Law Firm
- Latham & Watkins
- Lathrop GPM
- Law Offices of Ursula Taylor
- Levi & Korsinsky
- Lightfoot Franklin
- Lockridge Grindal
- Lowey Dannenberg
- Marion's Inn
- Matthew G. Miller PC
- Mayer Brown
- McCune Wright
- Mehri & Skalet
- Pallas Partners
- Parker Waichman
- Perkins Coie
- Pritzker Levine
- Reed Smith
- Robbins Geller
- Robbins Russell
- Robins Kaplan
- Saiber LLC
- Scott&Scott
- Sharp Law LLP
- Shook Hardy
- Sidley Austin
- Siegfried & Jensen
- Spencer Fane
- Spragens Law
- Squitieri & Fearon
- Steven Williams Law
- Strategic Health Law
- Wagstaff & Cartmell
- Weil Gotshal
- White & Case
- Williams & Connolly
- Willkie Farr
- Wilson Sonsini
- Yarmuth LLP
Companies
- Aetna Inc.
- Amerigroup Corp.
- Centene Corp.
- Change Healthcare Inc.
- Coventry Health Care Inc.
- CVS Health Corp.
- Express Scripts Holding Co.
- Humana Inc.
- King Pharmaceuticals Inc.
- MedImpact Healthcare Systems Inc.
- Meridian Medical Technologies Inc.
- Optum Inc.
- OptumRx Inc.
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- The Segal Co. Inc.
- UnitedHealth Group Inc.
- Viatris Inc.
Sectors & Industries:
-
August 20, 2018
Mylan, Pfizer Barely Put Dent In EpiPen Antitrust MDL
Mylan NV and Pfizer Inc. on Monday largely failed to scale down multidistrict litigation over sky-high prices for emergency allergy treatment EpiPen, as a Kansas federal judge mostly refused to throw out wide-ranging consumer claims of anti-competitive shenanigans.
-
June 12, 2018
Humana Ordered To Turn Over Docs In EpiPen Antitrust MDL
A Kansas federal judge on Monday ordered Humana Inc. to hand over within three weeks documents related to a multidistrict litigation accusing drugmaker Mylan NV of antitrust violations related to a surge in the price of its allergy treatment device, the EpiPen.
- ← Previous
- 1
- 2
- 3
- 4
- 5
- Next →